CABG Improves Outcomes in Patients With Ischemic Cardiomyopathy: 10-Year Follow-Up of the STICH Trial
The authors investigated the impact of coronary artery bypass grafting (CABG) on first and recurrent hospitalization in this population. In the STICH (Surgical Treatment for Ischemic Heart Failure) trial, CABG reduced all-cause death and hospitalization in patients with and ischemic cardiomyopathy a...
Gespeichert in:
Veröffentlicht in: | JACC. Heart failure 2019-10, Vol.7 (10), p.878-887 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The authors investigated the impact of coronary artery bypass grafting (CABG) on first and recurrent hospitalization in this population.
In the STICH (Surgical Treatment for Ischemic Heart Failure) trial, CABG reduced all-cause death and hospitalization in patients with and ischemic cardiomyopathy and left ventricular ejection fraction |
---|---|
ISSN: | 2213-1779 2213-1787 |
DOI: | 10.1016/j.jchf.2019.04.018 |